Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 161

1.

Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, multicenter study.

Pande AC, Feltner DE, Jefferson JW, Davidson JR, Pollack M, Stein MB, Lydiard RB, Futterer R, Robinson P, Slomkowski M, DuBoff E, Phelps M, Janney CA, Werth JL.

J Clin Psychopharmacol. 2004 Apr;24(2):141-9.

PMID:
15206660
2.

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.

Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.

Arch Gen Psychiatry. 2005 Sep;62(9):1022-30.

PMID:
16143734
3.

Efficacy of pregabalin in generalized social anxiety disorder: results of a double-blind, placebo-controlled, fixed-dose study.

Feltner DE, Liu-Dumaw M, Schweizer E, Bielski R.

Int Clin Psychopharmacol. 2011 Jul;26(4):213-20. doi: 10.1097/YIC.0b013e32834519bd.

PMID:
21368587
4.

Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.

Moon DE, Lee DI, Lee SC, Song SO, Yoon DM, Yoon MH, Kim HK, Lee YW, Kim C, Lee PB.

Clin Ther. 2010 Dec;32(14):2370-85. doi: 10.1016/j.clinthera.2011.01.014.

PMID:
21353106
5.

Efficacy and safety of pregabalin in elderly people with generalised anxiety disorder.

Montgomery S, Chatamra K, Pauer L, Whalen E, Baldinetti F.

Br J Psychiatry. 2008 Nov;193(5):389-94. doi: 10.1192/bjp.bp.107.037788.

7.

Long-term efficacy of pregabalin in generalized anxiety disorder.

Feltner D, Wittchen HU, Kavoussi R, Brock J, Baldinetti F, Pande AC.

Int Clin Psychopharmacol. 2008 Jan;23(1):18-28.

PMID:
18090504
8.

Efficacy of pregabalin in preventing relapse in patients with generalized social anxiety disorder: results of a double-blind, placebo-controlled 26-week study.

Greist JH, Liu-Dumaw M, Schweizer E, Feltner D.

Int Clin Psychopharmacol. 2011 Sep;26(5):243-51. doi: 10.1097/YIC.0b013e3283491fd5.

PMID:
21734588
9.

A randomized, double-blind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.

Feltner DE, Crockatt JG, Dubovsky SJ, Cohn CK, Shrivastava RK, Targum SD, Liu-Dumaw M, Carter CM, Pande AC.

J Clin Psychopharmacol. 2003 Jun;23(3):240-9.

PMID:
12826986
10.

Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.

Guan Y, Ding X, Cheng Y, Fan D, Tan L, Wang Y, Zhao Z, Hong Z, Zhou D, Pan X, Chen S, Martin A, Tang H, Cui L.

Clin Ther. 2011 Feb;33(2):159-66. doi: 10.1016/j.clinthera.2011.02.007. Epub 2011 Mar 27.

PMID:
21444113
11.

Fluvoxamine-controlled release formulation for the treatment of generalized social anxiety disorder.

Davidson J, Yaryura-Tobias J, DuPont R, Stallings L, Barbato LM, van der Hoop RG, Li D.

J Clin Psychopharmacol. 2004 Apr;24(2):118-25.

PMID:
15206657
12.

Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial.

Rosenstock J, Tuchman M, LaMoreaux L, Sharma U.

Pain. 2004 Aug;110(3):628-38.

PMID:
15288403
13.

Efficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.

Kasper S, Herman B, Nivoli G, Van Ameringen M, Petralia A, Mandel FS, Baldinetti F, Bandelow B.

Int Clin Psychopharmacol. 2009 Mar;24(2):87-96.

PMID:
21456104
14.

Early onset anxiolytic efficacy after a single dose of pregabalin: double-blind, placebo- and active-comparator controlled evaluation using a dental anxiety model.

Nutt D, Mandel F, Baldinetti F.

J Psychopharmacol. 2009 Nov;23(8):867-73. doi: 10.1177/0269881108094722. Epub 2008 Jul 17.

PMID:
18635690
15.
16.

Long-term treatment of anxiety disorders with pregabalin: a 1 year open-label study of safety and tolerability.

Montgomery S, Emir B, Haswell H, Prieto R.

Curr Med Res Opin. 2013 Oct;29(10):1223-30. doi: 10.1185/03007995.2013.820694. Epub 2013 Aug 19.

PMID:
23808960
17.

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia.

Arnold LM, Russell IJ, Diri EW, Duan WR, Young JP Jr, Sharma U, Martin SA, Barrett JA, Haig G.

J Pain. 2008 Sep;9(9):792-805. doi: 10.1016/j.jpain.2008.03.013. Epub 2008 Jun 3.

PMID:
18524684
18.

Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial.

Hadley SJ, Mandel FS, Schweizer E.

J Psychopharmacol. 2012 Apr;26(4):461-70. doi: 10.1177/0269881111405360. Epub 2011 Jun 21.

PMID:
21693549
19.

A randomized, double-blind, fixed-dose comparison of paroxetine and placebo in the treatment of generalized social anxiety disorder.

Liebowitz MR, Stein MB, Tancer M, Carpenter D, Oakes R, Pitts CD.

J Clin Psychiatry. 2002 Jan;63(1):66-74.

PMID:
11838629
20.

An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia.

Pauer L, Winkelmann A, Arsenault P, Jespersen A, Whelan L, Atkinson G, Leon T, Zeiher B; A0081100 Investigators.

J Rheumatol. 2011 Dec;38(12):2643-52. doi: 10.3899/jrheum.110569. Epub 2011 Oct 1.

PMID:
21965636

Supplemental Content

Support Center